We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$220M
Cap. Flow
+$92.2M
Cap. Flow %
5.11%
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$23M
2
MDLZ icon
Mondelez International
MDLZ
+$11.8M
3
GIS icon
General Mills
GIS
+$11.6M
4
JNJ icon
Johnson & Johnson
JNJ
+$8.36M
5
CRM icon
Salesforce
CRM
+$5.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$23.4M
2
V icon
Visa
V
+$13.3M
3
ADSK icon
Autodesk
ADSK
+$10.2M
4
PEP icon
PepsiCo
PEP
+$9.62M
5
ORCL icon
Oracle
ORCL
+$6.9M

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Healthcare 15.36%
3 Financials 15.12%
4 Consumer Discretionary 11.34%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RF icon
151
Regions Financial
RF
$26.8B
$1.99M 0.11%
108,636
+42,030
+63% +$791K
VRSN icon
152
VeriSign
VRSN
$26.4B
$1.98M 0.11%
+12,353
New +$1.89M
IDXX icon
153
Idexx Laboratories
IDXX
$46.5B
$1.98M 0.11%
7,918
+2,275
+40% +$552K
AMP icon
154
Ameriprise Financial
AMP
$49.5B
$1.97M 0.11%
13,327
+3,200
+32% +$458K
SPGI icon
155
S&P Global
SPGI
$119B
$1.95M 0.11%
+9,975
New +$2.06M
WMB icon
156
Williams Companies
WMB
$87.8B
$1.9M 0.11%
69,800
+35,540
+104% +$1.03M
SIVB
157
DELISTED
SVB Financial Group
SIVB
$1.9M 0.11%
6,100
+2,200
+56% +$694K
LH icon
158
Labcorp
LH
$25.7B
$1.89M 0.1%
12,641
+3,492
+38% +$531K
VLO icon
159
Valero Energy
VLO
$87.2B
$1.88M 0.1%
+16,485
New +$1.87M
NEM icon
160
Newmont
NEM
$111B
$1.87M 0.1%
61,887
+24,450
+65% +$827K
COR icon
161
Cencora
COR
$62B
$1.86M 0.1%
20,215
+4,700
+30% +$407K
ABMD
162
DELISTED
Abiomed Inc
ABMD
$1.85M 0.1%
4,120
+1,326
+47% +$523K
CFG icon
163
Citizens Financial Group
CFG
$30.5B
$1.85M 0.1%
47,915
+11,870
+33% +$479K
CERN
164
DELISTED
Cerner Corp
CERN
$1.84M 0.1%
+28,550
New +$1.82M
AIG icon
165
American International
AIG
$42.4B
$1.84M 0.1%
34,520
-145
-0.4% -$7.78K
HIG icon
166
Hartford Financial Services
HIG
$39.6B
$1.82M 0.1%
36,535
+9,500
+35% +$488K
A icon
167
Agilent Technologies
A
$39.9B
$1.82M 0.1%
25,810
+3,800
+17% +$251K
CCI icon
168
Crown Castle
CCI
$31.9B
$1.82M 0.1%
16,345
+100
+0.6% +$11.1K
BR icon
169
Broadridge
BR
$18.8B
$1.8M 0.1%
13,673
+8,775
+179% +$1.11M
SRE icon
170
Sempra
SRE
$55.1B
$1.79M 0.1%
31,422
+9,600
+44% +$556K
EFX icon
171
Equifax
EFX
$20.7B
$1.78M 0.1%
13,627
+4,000
+42% +$521K
AME icon
172
Ametek
AME
$57.6B
$1.77M 0.1%
22,360
+5,600
+33% +$429K
CXO
173
DELISTED
CONCHO RESOURCES INC.
CXO
$1.76M 0.1%
+11,550
New +$1.63M
CI icon
174
Cigna
CI
$72.7B
$1.76M 0.1%
8,465
+50
+0.6% +$9.27K
ABBV icon
175
AbbVie
ABBV
$431B
$1.76M 0.1%
18,632
-2,400
-11% -$228K
5 6
7
8 9

Similar funds

MF
MHI Funds Woodstock, New York $34.7M AUM 17.93% 1-Year Est. Return
AIM
Act II Management New York $33.8M AUM 8.86% 1-Year Est. Return
QCMA
Quad Capital Management Advisors New York $31.4M AUM 22.55% 1-Year Est. Return
SC
Salzman & Co Pittsford, New York $29.7M AUM 12.12% 1-Year Est. Return
BIM
Beach Investment Management West Conshohocken, Pennsylvania $28.8M AUM 11.57% 1-Year Est. Return
GP
Gresham Partners Chicago, Illinois $26.2M AUM 18.05% 1-Year Est. Return
GAM
GQ Asset Management New York City, New York $52.7M AUM 8.84% 1-Year Est. Return
SCM
Shoals Capital Management Arlington, Virginia $21.5M AUM 38.8% 1-Year Est. Return

Oakbrook Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.

  • Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
  • Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
  • Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
  • Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
  • Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
  • Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
  • Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.